The Labour manifesto pledged to “maximise our potential to lead the world in clinical trials”. With our regulatory advantage ...

Berger Montague, a national plaintiffs' law firm, is pleased to announce that Joel M. Sweet has returned to the Firm after serving as an Assistant U.S. Attorney for the Eastern District of ...

As the biosimilar industry celebrates a decade of growth, the market continues to evolve with expanded treatment options, cost savings, and a flurry of new competitors—yet regulatory challenges, ...